OA
CRL icon

OFI Advisors’s Charles River Laboratories CRL Stock Holding History

OFI Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$207K Sell
3,258
-126
-4% -$9.05K 0.01% 1188
2015
Q2 		$238K Buy
3,384
+515
+18% +$38.1K 0.01% 1159
2015
Q1 		$227K Sell
2,869
-221
-7% -$16.3K 0.01% 1182
2014
Q4 		$197K Sell
3,090
-862
-22% -$54K 0.01% 1217
2014
Q3 		$236K Buy
3,952
+336
+9% +$19.2K 0.02% 1053
2014
Q2 		$194K Buy
3,616
+799
+28% +$43.8K 0.01% 1173
2014
Q1 		$170K Sell
2,817
-55
-2% -$3.21K 0.01% 1180
2013
Q4 		$152K Buy
2,872
+64
+2% +$3.21K 0.01% 1219
2013
Q3 		$130K Sell
2,808
-107
-4% -$4.91K 0.01% 1207
2013
Q2 		$120K Buy
+2,915
New +$125K 0.01% 1170

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

OFI Advisors's CRL Position: Q3 2015 in Review

OFI Advisors reduced its Charles River Laboratories (CRL) stake by 3.7% in Q3 2015, selling an estimated $9.05K and leaving 3,258 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #1188.

OFI Advisors first reported a position in CRL in Q2 2013 and has held it in 10 quarters since. The position peaked at $238K in Q2 2015. 258 funds tracked by Wall St. Rank hold CRL as of Q3 2015.

  • OFI Advisors held 3,258 shares of Charles River Laboratories worth $207K as of Q3 2015.
  • OFI Advisors sold 126 Charles River Laboratories shares in Q3 2015, an estimated $9.05K.
  • Charles River Laboratories made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1188 holding.
  • OFI Advisors first reported a position in Charles River Laboratories in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Charles River Laboratories position peaked at $238K in Q2 2015.
  • 258 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.